• No Chemo; Rituximab Alone for Indolent Lymphoma?

    1 month ago - By Medscape

    New results showing a 10-year overall survival rate of 73% with rituximab alone suggest that patients can skip chemotherapy. But this may not be appropriate for all patients, suggests an expert.
    Medscape Medical News
    Read more ...